Chemical and molecular aspects on interactions of galanthamine and its derivatives with cholinesterases

• Published in: Current pharmaceutical biotechnology Vol. 16; no. 3; p. 252
• Main Authors: Gulcan, Hayrettin O, Orhan, Ilkay E, Sener, Bilge
• Format: Journal Article
• Language: English
• Published: Netherlands 01-01-2015
• Subjects: Animals; Binding Sites - physiology; Cholinesterase Inhibitors - chemistry; Cholinesterase Inhibitors - metabolism; Cholinesterases - metabolism; Drug Interactions - physiology; Galantamine - chemistry; Galantamine - metabolism; Humans; Structure-Activity Relationship
• ISSN: 1873-4316
• DOI: 10.2174/1389201015666141202105105

Dual action of galanthamine as potent cholinesterase inhibitor and nicotinic modulator has attracted a great attention to be used in the treatment of AD. Consequently, galanthamine, a natural alkaloid isolated from a Galanthus species (snowdrop, Amaryllidaceae), has become an attractive model compound for synthesis of its novel derivatives to discover new drug candidates. Numerous studies have been done to elucidate interactions between galanthamine and its different derivatives and the enzymes; acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) using in vitro and in silico experimental models. The in vitro studies revealed that galanthamine inhibits AChE in strong, competitive, long-acting, and reversible manner as well as BChE, although its selectivity towards AChE is much higher than BChE. The in silico studies carried out by employing molecular docking experiments as well as molecular dynamics simulations pointed out to existence of strong interactions of galanthamine with the active gorge of AChE, mostly of Torpedo californica (the Pasific electric ray) origin. In this review, we evaluate the mainstays of cholinesterase inhibitory action of galanthamine and its various derivatives from the point of view of chemical and molecular aspects.